rs1859887

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001372.4(DNAH9):​c.12060G>A​(p.Thr4020Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.304 in 1,613,610 control chromosomes in the GnomAD database, including 77,315 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.26 ( 5567 hom., cov: 31)
Exomes 𝑓: 0.31 ( 71748 hom. )

Consequence

DNAH9
NM_001372.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -5.21

Publications

15 publications found
Variant links:
Genes affected
DNAH9 (HGNC:2953): (dynein axonemal heavy chain 9) This gene encodes the heavy chain subunit of axonemal dynein, a large multi-subunit molecular motor. Axonemal dynein attaches to microtubules and hydrolyzes ATP to mediate the movement of cilia and flagella. The gene expresses at least two transcript variants; additional variants have been described, but their full length nature has not been determined. [provided by RefSeq, Jul 2008]
DNAH9 Gene-Disease associations (from GenCC):
  • ciliary dyskinesia, primary, 40
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • situs inversus
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • schizophrenia
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 17-11930048-G-A is Benign according to our data. Variant chr17-11930048-G-A is described in ClinVar as Benign. ClinVar VariationId is 402785.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-5.2 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.326 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH9NM_001372.4 linkc.12060G>A p.Thr4020Thr synonymous_variant Exon 63 of 69 ENST00000262442.9 NP_001363.2 Q9NYC9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH9ENST00000262442.9 linkc.12060G>A p.Thr4020Thr synonymous_variant Exon 63 of 69 1 NM_001372.4 ENSP00000262442.3 Q9NYC9-1
DNAH9ENST00000608377.5 linkc.996G>A p.Thr332Thr synonymous_variant Exon 9 of 15 1 ENSP00000476951.1 Q9NYC9-3
DNAH9ENST00000396001.6 linkn.1523G>A non_coding_transcript_exon_variant Exon 9 of 15 1
DNAH9ENST00000454412.6 linkc.11878-1966G>A intron_variant Intron 62 of 67 5 ENSP00000414874.2 E7EP17

Frequencies

GnomAD3 genomes
AF:
0.255
AC:
38763
AN:
151868
Hom.:
5565
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.107
Gnomad AMI
AF:
0.255
Gnomad AMR
AF:
0.252
Gnomad ASJ
AF:
0.353
Gnomad EAS
AF:
0.194
Gnomad SAS
AF:
0.317
Gnomad FIN
AF:
0.318
Gnomad MID
AF:
0.306
Gnomad NFE
AF:
0.330
Gnomad OTH
AF:
0.291
GnomAD2 exomes
AF:
0.285
AC:
71418
AN:
250712
AF XY:
0.293
show subpopulations
Gnomad AFR exome
AF:
0.103
Gnomad AMR exome
AF:
0.199
Gnomad ASJ exome
AF:
0.361
Gnomad EAS exome
AF:
0.202
Gnomad FIN exome
AF:
0.317
Gnomad NFE exome
AF:
0.330
Gnomad OTH exome
AF:
0.317
GnomAD4 exome
AF:
0.309
AC:
451515
AN:
1461622
Hom.:
71748
Cov.:
39
AF XY:
0.312
AC XY:
226515
AN XY:
727104
show subpopulations
African (AFR)
AF:
0.0966
AC:
3234
AN:
33476
American (AMR)
AF:
0.209
AC:
9331
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.357
AC:
9324
AN:
26126
East Asian (EAS)
AF:
0.164
AC:
6517
AN:
39692
South Asian (SAS)
AF:
0.313
AC:
27006
AN:
86240
European-Finnish (FIN)
AF:
0.318
AC:
16980
AN:
53396
Middle Eastern (MID)
AF:
0.343
AC:
1981
AN:
5768
European-Non Finnish (NFE)
AF:
0.323
AC:
358923
AN:
1111838
Other (OTH)
AF:
0.302
AC:
18219
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
17187
34375
51562
68750
85937
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11412
22824
34236
45648
57060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.255
AC:
38764
AN:
151988
Hom.:
5567
Cov.:
31
AF XY:
0.256
AC XY:
18982
AN XY:
74268
show subpopulations
African (AFR)
AF:
0.107
AC:
4448
AN:
41496
American (AMR)
AF:
0.253
AC:
3856
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.353
AC:
1225
AN:
3470
East Asian (EAS)
AF:
0.194
AC:
995
AN:
5134
South Asian (SAS)
AF:
0.317
AC:
1525
AN:
4808
European-Finnish (FIN)
AF:
0.318
AC:
3351
AN:
10554
Middle Eastern (MID)
AF:
0.303
AC:
89
AN:
294
European-Non Finnish (NFE)
AF:
0.330
AC:
22432
AN:
67952
Other (OTH)
AF:
0.290
AC:
610
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1387
2774
4161
5548
6935
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
412
824
1236
1648
2060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.296
Hom.:
3120
Bravo
AF:
0.240
Asia WGS
AF:
0.237
AC:
821
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
0.31
DANN
Benign
0.65
PhyloP100
-5.2
Mutation Taster
=89/11
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1859887; hg19: chr17-11833365; COSMIC: COSV52341635; COSMIC: COSV52341635; API